In November, FDA’s device center will select which app is welcomed into the program, and the selected will have amplified interactions with FDA during the progress of their products. FDA will grant the advanced device nomination to products that meet the permitted criteria without requiring a separate application.
Denmark-based, Novo Nordisk developed a drug that stimulates insulin productions called semaglutide a class of drugs which categorized in GLP-1s. The new oral diabetes medicine is a better lowering blood sugar levels compared to the existing drug.
With a view to reducing waiting time for patients, a group of doctors in a Nigerian hospital has unveiled a mobile app. The app is expected to bring a paradigm change in healthcare delivery services in the country.
In a major setback for Eisai and Merck & Co, the FDA has stalled the roll-out of Lenvima as a treatment for earlier untreated liver cancer patients. Big things were expected by Merck & Co when Eisai’s Lenvima was scheduled to be launched in March. Merck has agreed to shell out USD 5.8 billion on half of the liver cancer’s drug sales.
Cincinnati-based startup Eccrine System has developed a health wearable devices called Sweatronics which tracks your health using sweat. Other bodily fluids like urine and blood contain plenty of the body information’s but are not as easy to collect. However, Sweatronics needs only sweat samples that is produces automatically while working or even sleeping.
According to the World Health Organization, nearly 600 million illnesses and 420,000 deaths due to food pathogens are reported every year. Now, our scientific field has delivered more reliable and user-friendly methods to detect the status of contamination and the presence of pathogens on food items, if any.
University College London Hospital (UCLH) and the Alan Turing Institute are working together on Artificial Intelligence to carry out works which are traditionally done by the doctors and nurses; from deciding which accidental and emergency patients to be consulted first to diagnosing cancer on CT scan.
Patients and Beijing residents are currently benefitting from the new electronic health cards issued by Beijing through the WeChat app; the program is facilitated by Tencent and Sinosoft Technology which is aimed to improve the healthcare services by 2030 through digital cards.
Aimovig, a ground-breaking drug to prevent Migraines was approved by the FDA last week. Aimovig will be the only player in the market to treat migraines. The new drug has to be taken once a month through an injection similar to an insulin shot or an EpiPen.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.